The haemolytic action of dapsone: changes in the red-cell membrane.
D000110:Acetylcholinesterase / Q000097:blood; D000328:Adult; D000368:Aged; D002374:Catalase / Q000097:blood; D002462:Cell Membrane / Q000187:drug effects; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003622:Dapsone / Q000009:adverse effects*; D003874:Dermatitis Herpetiformis / Q000188:drug therapy; D004912:Erythrocytes / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D005978:Glutathione / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D009996:Osmotic Fragility; D010545:Peroxides / Q000378:metabolism; D010743:Phospholipids / Q000097:blood; D011188:Potassium / Q000097:blood; D013438:Sulfhydryl Compounds; D014810:Vitamin E / Q000494:pharmacology
D002729:Chloromercuribenzoates; D010545:Peroxides; D010743:Phospholipids; D013438:Sulfhydryl Compounds; D014810:Vitamin E; D003622:Dapsone; D002374:Catalase; D000110:Acetylcholinesterase; D005978:Glutathione; D003545:Cysteine; D011188:Potassium